Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
Operation Warp Speed’s Big Vaccine Contracts Could Stay Secret Medical Countermeasures September 29, 2020 …
Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development Antimicrobial Resistance September 28, 2020 …
Remdesivir: Second Mechanism of Action Against SARS-CoV-2 Revealed in New Study Medical Countermeasures September 23, 2020 …
NIH Expands COVID-19 Convalescent Plasma Clinical Trials Medical Countermeasures September 22, 2020 …
HHS Pushes Out COVID-19 Mass Vaccination Playbook, Distribution Strategy Medical Countermeasures September 16, 2020 …
The Big 3 Infectious Diseases Besides COVID-19 Scientists Are Trying to Find a Vaccine For Medical Countermeasures September 14, 2020 …
COVID-19 Industry Rivals Plan Joint Pledge on Vaccine Safety Medical Countermeasures September 4, 2020 …
The Challenge of Vaccine Cold Chain Logistics: How a Chemical ‘Casing’ Could Save Lives Medical Countermeasures September 4, 2020 …
Lessons From Hydroxychloroquine: Improving FDA’s Authorization and Approval Process Medical Countermeasures August 31, 2020 …
USAMRIID Scientists Engineer First Lethal Mouse Model for COVID-19 Medical Countermeasures August 27, 2020 …
Vaccine Approval Is Just The Beginning – Huge Production Challenges Await Medical Countermeasures August 24, 2020 …
UC Riverside Scientists Use AI to Drive COVID Countermeasure Discovery Medical Countermeasures August 12, 2020 …
NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials Medical Countermeasures July 28, 2020 …
Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial Medical Countermeasures July 14, 2020 …
Many Flu Strains May Be Capable of Mutating to Escape Universal-Vaccine Antibodies Medical Countermeasures June 24, 2020 …
Funding for Preclinical Development of Countermeasures Against Select Pathogens Contracts + Grants June 8, 2020 …
Promising Results from Phase 1 Trial of Equine Encephalitis Virus Vaccine Medical Countermeasures June 8, 2020 …
AstraZeneca Teams with Oxford Biomedica to Shore Up COVID-19 Vaccine Manufacturing Capacity Industry News May 28, 2020 …
GSK Announces Plans to Produce 1 Billion Doses of Pandemic Vaccine Adjuvant in 2021 Industry News May 28, 2020 …
